{
    "2018-06-11": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Cramer: Remix: What Trumpâ€™s endgame with China could really be about",
                "features": {
                    "keywords": [
                        "Trump",
                        "China",
                        "endgame"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "international trade"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Jim Cramer: Many Reasons Why a Stock Market You Think Should Go Down, Doesn't",
                "features": {
                    "keywords": [
                        "stock market",
                        "reasons",
                        "down"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Cramer: Eli Lilly's share price recovery symbolizes this ...",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "share price",
                        "recovery"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Market attitude seen in Eli Lilly's share price recovery",
                "features": {
                    "keywords": [
                        "market attitude",
                        "Eli Lilly",
                        "share price recovery"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AstraZeneca's Tagrisso Wins EU Nod for First-Line Lung Cancer",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Tagrisso",
                        "EU",
                        "lung cancer"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "JAK Inhibitors' Prospects Strong: 4 Stocks Ruling the Space",
                "features": {
                    "keywords": [
                        "JAK Inhibitors",
                        "prospects",
                        "stocks"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Amgen's Prolia Gets Label Expansion Approval in Europe",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Prolia",
                        "label expansion",
                        "Europe"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie/Roche's Leukemia Drugs Combination Gets FDA Approval",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Roche",
                        "leukemia drugs",
                        "FDA approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AbbVie",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Bristol Myers",
                        "Merck",
                        "Roche",
                        "Lilly",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Elanco Animal Health Introduces New Respiratory PRRS Vaccine",
                "features": {
                    "keywords": [
                        "Elanco",
                        "animal health",
                        "PRRS vaccine"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "veterinary medicine"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Lilly to Unveil New Data at the Annual European Congress of Rheumatology, Furthering Commitment to Scientific Discovery in Immunology",
                "features": {
                    "keywords": [
                        "Lilly",
                        "data",
                        "European Congress",
                        "rheumatology",
                        "immunology"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}